Download the WIN 2020 Program
Integrating Genomics and Transcriptomics to reshape Precision Oncology: A WINning Strategy |
||||
|
SUNDAY 21st JUNE, 2020 |
||||
|
|
Welcome and Opening Remarks |
Richard L. Schilsky |
Chairman WIN Consortium, Villejuif, France |
|
|
Josep Tabernero |
Vice-Chairman WIN Consortium, Villejuif, France |
|||
|
PRESIDENTIAL SESSION 1: BEYOND DNA TESTING: PLACE OF TRANSCRIPTOMICS IN PRECISION ONCOLOGY |
||||
|
|
Opening Keynote Lecture Expression profiling to discover molecularly and clinically distinct cancer subtypes and to predict response to therapy |
Louis M. Staudt |
National Cancer Institute (NCI), Bethesda, USA |
|
|
|
Proteomics in Precision Oncology |
Gordon B. Mills |
Knight Cancer Institute, Oregon Health & Science University (OHSU), Portland, USA |
|
|
|
Keynote Lecture: Functional genomics to identify cancer vulnerabilities |
René Bernards |
Netherland Cancer Institute (NKI), Amsterdam, Netherlands |
|
|
|
Molecular profiling of pediatric cancers |
Elaine R. Mardis |
Nationwide Children’s Hospital, Columbus, USA |
|
|
|
Harnessing a synthetic lethality analysis for patient stratification: WINTHER trial |
Eytan Ruppin |
National Institute of Health (NIH), Bethesda, USA |
|
|
SESSION 2: NOVEL ALGORITHMS AND DATA VISUALIZATION STRATEGIES TO INTEGRATE GENOMICS AND TRANSCRIPTOMICS |
||||
|
|
SIMS algorithm and Digital Display |
Vladimir Lazar |
WIN Consortium, Villejuif, France |
|
|
|
Molecular artificial intelligence to predict patient treatment response |
David Spetzler |
Caris Life Sciences, Irving, USA |
|
|
|
RNAseq: technological shift enabling efficient transcriptomics |
Kevin White |
Tempus, Chicago, USA |
|
WIN 2021 Symposium
c/o MCI UK Ltd
Durford Mill
Petersfield
GU31 5AZ
Tel: +44 (0) 1730 715223
General enquiries: winsymposium@mci-group.com
Sponsorship enquiries: winsymposium@mci-group.com
Abstract enquiries: winsympabstracts@mci-group.com
Registration enquiries: winsympreghot@mci-group.com